Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $887M (100.0% shares, 0.0% debt)

Holdings (38)

INSM INSMED INC 13.5%
Value $120M Shares 4,423,369 Est. Cost $17.79 Unrealized +57.3%
FOLD AMICUS THERAPEUTICS INC 12.4%
Value $110M Shares 9,344,102 Est. Cost $9.63 Unrealized +32.9%
BMRN BIOMARIN PHARMACEUTICAL INC 11.2%
Value $99.09M Shares 1,134,569 Est. Cost $83.16 Unrealized +7.7%
BIIB BIOGEN INC 7.1%
Value $62.52M Shares 289,958 Est. Cost $264.98 Unrealized -11.6%
UTHR UNITED THERAPEUTICS CORP 6.9%
Value $61.51M Shares 267,759 Est. Cost $89.23 Unrealized +152.9%
STAA STAAR SURGICAL CO 6.0%
Value $52.81M Shares 1,379,590 Est. Cost $24.23 Unrealized +34.2%
ACAD ACADIA PHARMACEUTICALS INC 5.0%
Value $44.65M Shares 2,414,943 Est. Cost $28.41 Unrealized -12.8%
PRTA PROTHENA CORP PLC 4.6%
Value $41.2M Shares 1,663,448 Est. Cost $21.46 Unrealized +38.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 3.5%
Value $31.31M Shares 2,112,811 Est. Cost $5.23 Unrealized +122.4%
ALNY ALNYLAM PHARMACEUTICALS INC 3.1%
Value $27.31M Shares 182,766 Est. Cost $169.79 Unrealized -1.8%
SRPT SAREPTA THERAPEUTICS INC 2.9%
Value $26.06M Shares 201,265 Est. Cost $111.32 Unrealized +10.0%
REVANCE THERAPEUTICS INC 2.9%
Value $25.82M Shares 5,248,004 Est. Cost $21.40 Unrealized
SAGE THERAPEUTICS INC 2.1%
Value $18.85M Shares 1,005,776 Est. Cost $42.50 Unrealized
ANAB ANAPTYSBIO INC 2.0%
Value $18.01M Shares 799,906 Est. Cost $19.13 Unrealized +23.8%
EHTH EHEALTH INC 1.8%
Value $16.38M Shares 2,715,681 Est. Cost $38.13 Unrealized -82.6%
ALGN ALIGN TECHNOLOGY INC 1.8%
Value $16.1M Shares 49,105 Est. Cost $149.18 Unrealized +96.7%
ALKS ALKERMES PLC 1.5%
Value $13.42M Shares 495,592 Est. Cost $22.36 Unrealized +27.0%
ACELYRIN INC 1.3%
Value $11.58M Shares 1,715,180 Est. Cost $6.75 Unrealized
NEVRO CORP 1.2%
Value $10.84M Shares 750,371 Est. Cost $21.87 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 1.1%
Value $9.644M Shares 405,193 Est. Cost $16.84 Unrealized +32.5%
NVCR NOVOCURE LTD 1.0%
Value $8.783M Shares 561,908 Est. Cost $58.84 Unrealized -75.0%
CYTK CYTOKINETICS INC 0.9%
Value $7.832M Shares 111,717 Est. Cost $6.71 Unrealized +1052.1%
KARYOPHARM THERAPEUTICS INC 0.9%
Value $7.704M Shares 5,102,193 Est. Cost $16.36 Unrealized
VERVE THERAPEUTICS INC 0.9%
Value $7.647M Shares 575,817 Est. Cost $13.94 Unrealized
GOSS GOSSAMER BIO INC 0.9%
Value $7.542M Shares 6,391,775 Est. Cost $1.58 Unrealized -30.3%
ELEVATION ONCOLOGY INC 0.8%
Value $6.908M Shares 1,346,666 Est. Cost $5.13 Unrealized
BLUEBIRD BIO INC 0.7%
Value $5.837M Shares 4,560,171 Est. Cost $1.35 Unrealized
RLMD RELMADA THERAPEUTICS INC 0.4%
Value $3.406M Shares 732,400 Est. Cost $3.27 Unrealized +47.3%
NUVB NUVATION BIO INC 0.3%
Value $2.812M Shares 772,652 Est. Cost $1.92 Unrealized 0.0%
TSHA TAYSHA GENE THERAPIES INC 0.3%
Value $2.328M Shares 811,268 Est. Cost $2.02 Unrealized +2.9%
STOK STOKE THERAPEUTICS INC 0.2%
Value $1.699M Shares 125,861 Est. Cost $6.06 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value $1.625M Shares 64,700 Est. Cost $15.56 Unrealized +76.7%
HUM HUMANA INC 0.2%
Value $1.382M Shares 3,985 Est. Cost $369.63 Unrealized 0.0%
VYNE VYNE THERAPEUTICS INC 0.2%
Value $1.367M Shares 445,434 Est. Cost $3.12 Unrealized -30.9%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $854K Shares 110,719 Est. Cost $23.56 Unrealized -64.2%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $737K Shares 225,465 Est. Cost $5.95 Unrealized -44.7%
ACRS ACLARIS THERAPEUTICS INC 0.1%
Value $707K Shares 569,832 Est. Cost $1.19 Unrealized 0.0%
URGN UROGEN PHARMA LTD 0.0%
Value $368K Shares 24,500 Est. Cost $27.01 Unrealized -39.5%